Topic Listing for Harbor BioSciences, Inc.

Able Ontents Accounting Stock-based Compensation
Accrued Expenses Action Without Meeting
Acute Radiation Syndrome Ars Additional Information
Additional Irhs Other Autoimmune Disease Additional Symposium Highlights
Address Principal Executive Offices Zip Code Adjustments
Administration Aeson Therapeutics
Afrri Collaboration Agent Warrants
Agreed Acknowledged Also Provides Update Discussions Hhs Status Neumune
Amendment Amendment Employment Agreement
Amendment Rights Amendment Sublease
Amendments Amendments Articles Incorporation Bylaws Change
Annual Meeting Annual Report
Approval 2005 Equity Incentive Plan Approval 2005 Non-employee Directors Equity Incentive Plan
Approval Process Ase Alary
Assignment Form Atification Election Ndependent Egistered Ublic Ccounting Irm
Atification Election Ndependent Registered Public Accounting Firm Audit Committee
Basis Presentation Because Stock Ownership Concentrated Other Investors Minimal Influence
Been Changes Internal Controls Over Financial Reporting Period Beneficial Owner Shares Registered Name Broker Bank
Beneficial Ownership Reporting Compliance Board Directors Recommends Vote Favor Proposal
Brendan Mcdonnell Cancer
Cash Equivalents Caution Forward-looking Statements
Cautionary Statement Regarding Forward-looking Statements Certain Confidential Information Contained Document Marked Brackets Been
Certain Restrictions Certain Transactions
Certificate Rights Certification
Change Vote After Submitting Proxy Changes Capital Structure
Changes Internal Control Over Financial Reporting Changes Stockholder Nomination Procedures
Clinical Development Programs Code Business Conduct Ethics
Colthurst Edenland Prendergast Committees
Common Stock Financings Common Stock Par Value Per Share
Comparison Cumulative Total Return Investment Compensation
Compensation Committee Compensation Committee Report
Compensation Philosophy Named Executive Officers Overview Competition
Concentrations Risk Confidential
Confidentiality Agreements Employees Others Not Adequately Prevent Disclosure Congressional Pharmaceutical
Consent Independent Registered Public Accounting Firm Consideration Services Rendered Agreement Agrees Pay Following Fees
Consolidation Merger Sale Transfer Assets Earning Power Consulting Warrant
Consulting Warrants Controls Procedures
Convertible Warrants Copy Annual Report Securities Exchange Form 10-k 2004
Corporate Governance Management Corporate Seal
Corporate Transactions Changes Control Covenants Parties
Critical Accounting Policies Delaware General Corporation Law
Delays Conduct Completion Preclinical Clinical Studies Analysis Data Delegation Committee
Delisted Nasdaq Global Market Materially Limit Trading Common Delisted Nasdaq National Market Materially Limit Trading Common
Describe Variations Invention Accomplish Same Similar Results Example Description
Detachment Transfer Rights Detailed Information Available Form 10-k Scheduled Filed Today
Detailed Information Available Form 10-k Was Filed Today Detailed Information Available Form 10-k Was Filed Yesterday
Detailed Information Available Form 10-q Was Filed 2008 Director Compensation
Director Independence Director Listed Below Proposal
Director Listed Below Proposals Directors
Directors Plan Discretionary Cash Bonuses
Dividends Dividends Distributions
Djustments Hanges Ommon Tock Ther Orporate Vents Dministration
Documents Incorporated Reference Drug Candidates Development
Duration Termination Amendment Duties
Each Placement Agents Hereby Waives Right Trial Jury Eastgate Mall Suite 400 San Diego 92121
Ecitals Ection 162
Ection Eneficial Wnership Eporting Ompliance Effect Between Parties
Effective Date Means Plan Document Approved Stockholders Efinitions
Eligibility Employees
Employment Agreement Employment Severance Change Control Agreements
Employment Term Eneral
Ension Enefits Entry Material Definitive Agreement
Eport Ompensation Ommittee Oard Irectors Xecutive Eport Udit Ommittee Oard Irectors
Equity Compensation Plan Information Equity Financing
Equity Plan Equity Transactions
Erformance Ased Nnual Ncentive Onus Ermination Uspension Lan
Ertain Ransactions Estimates
Evaluation Disclosure Controls Procedures Exact Name Registrant Specified Charter
Exchange Executive
Executive Compensation Decisions Executive Compensation Philosophy Objectives
Executive Compensation Review Process Executive Officers
Executive Officers Senior Management Exercisability Rights
Exercise Notice Exhibits
Existing Future Pricing Regulations Reimbursement Limitations Limit Potential Existing Pricing Regulations Reimbursement Limitations Limit Potential Profits
Existing Pricing Regulations Reimbursement Limitations Reduce Potential Profits Explanatory
Explanatory Statement Face Product Liability Claims Related Misuse Drug Candidates
Face Product Liability Claims Related Misuse Products Cause Failure Protect Proprietary Technology Impair Competitive Position
Federal Income Tax Information Financial Instruments
Financial Results Financial Statements Exhibits
Financing Warrants Find Out Results Voting Annual Meeting
Fixing Record Dates Focus Core Technology Metabolic Disorders Autoimmunity Cancer
Form 10-k Form 10-q
Form Assignment Form Election Purchase
Form Exercise Notice Form Offer Notice
Form Patent Notice Form Reclamation Notice
Form Release Form Right Certificates
Former Name Address Changed Since Last Report Forward-looking Statements
Founder Richard Hollis Longer Officer Director General
General Overview Ggregated Ption Xercises Ast Iscal Ear
Government Regulation Greement
Hares Ubject Lan He3235
Health Human Services Acute Radiation Syndrome Candidate Held 2005
Held 2006 Held 2007
Held 2008 Held 2009
Hematopoiesis Hief Xecutive Fficer Ompensation
Hoice Hold Conference Call 1100 Est 2007
Hollis-eden Hollis-eden Announces 2005 Financial Results
Hollis-eden Announces Financial Results 2005 Hollis-eden Pharmaceuticals
Hollis-eden Pharmaceuticals Announces 100 Financing Hollis-eden Pharmaceuticals Announces 2006 Financial Results
Hollis-eden Pharmaceuticals Announces Decision Arbitration Hollis-eden Pharmaceuticals Announces Financial Results 2006
Hollis-eden Pharmaceuticals Announces Financial Results 2007 Hollis-eden Pharmaceuticals Inc
Hollis-eden Pharmaceuticals Receives Nasdaq Notification Related Minimum Bid Hollis-eden Pharmaceuticals Reports Year-end 2008 Financial Results
Hollis-edens Approach Hormonal Signaling Technology Platform
Iac Management Warrants Identity Written Documents Contain Supporting Data Including Notebook
Immune Regulating Hormones Immunitin
Immunitin Other Irhs Infectious Disease Impact Recently Issued Accounting Pronouncements
Important Notice Regarding Availability Proxy Materials Stockholder Meeting Income Taxes
Indemnification Directors Executive Officers Other Employees Agents Index
Index Exhibits Inducement Awards
Inflammation Inflammatory Conditions
Inflammatory Diseases Inflammatory Diseases Cystic Fibrosis
Inflammatory Diseases Rheumatoid Arthritis Inflammatory Diseases Ulcerative Colitis
Inflammatory Diseases Ulcerative Colitis Rheumatoid Arthritis Innate Cell-mediated Immunity
Invention Description Investor Relations Warrant
Irector Ompensation Irector Ompensation Iscal 2006
Irector Ompensation Iscal 2007 Irector Ompensation Iscal 2008
Irector Ompensation Iscal Ear 2008 Irectors Ontinuing Ffice Ntil 2006 Nnual Eeting
Irectors Ontinuing Ffice Ntil 2007 Nnual Eeting Irectors Ontinuing Ffice Ntil 2008 Nnual Eeting
Irectors Ontinuing Ffice Ntil 2009 Nnual Eeting Irectors Ontinuing Ffice Ntil 2010 Nnual Eeting
Irhs Autoimmune Disease Irhs Chemotherapy Protection
Irhs Metabolic Disorders Irhs Pulmonary Diseases
Iscellaneous Issuance Sale Registered Securities Warrant Purchase
Issuance Sale Registered Securities Warrants Purchase Issue Right Certificates
Issuing Preferred Stock Rights Senior Those Common Adversely James Frincke Phd
Jerome Hauer Lection Irectors
Legal Opinion Legal Proceedings
Letterhead Cooley Godward Kronish Llp Letterhead Cooley Godward Llp
Ligibility Liquidity Capital Resources
Listing Exhibits Litigation Expensive Time Consuming Adversely Affect Operations
Litigation Matters Litigation Matters Colthurst Edenland Prendergast
Litigation Other Disputes Regarding Patents Proprietary Rights Expensive Loans Officers
Lose Services Members Management Team Fail Attract Retain Lose Services Richard Hollis Fail Attract Retain Qualified
Lowers Fasting Glucose Levels Obese Insulin Resistant Subjects Managements Discussion Analysis Financial Condition Results Operations
Managements Report Internal Control Over Financial Reporting Manufacturers Drug Candidates Not Comply Current Good Manufacturing
Manufacturers Products Not Comply Current Good Manufacturing Practices Manufacturing
Marc Sarni Market Treating Acute Radiation Syndrome Uncertain
Market Treating Acute Radiation Syndrome Uncertain Development Plans Matching Contributions
Material Modification Rights Security Holders Material Tax Accounting Implications Executive Compensation Policies
Meetings Mendment 2005 Mployee Irectors Quity Ncentive Lan
Mendment 2005 Quity Ncentive Lan Metabolic Disorders
Metabolic Disorders Type Diabetes Miscellaneous
Mployment Everance Hange Ontrol Greements Name Person Filing Proxy Statement Other Registrant
Names Other Persons Aware Invention Dates Approximate They Names Others Contributed Discovery Conception Invention
Ndependence Oard Irectors Ndependent Egistered Ublic Ccounting Irm Ees
Ndex Need Raise Additional Money Before Achieve Profitability Fail
Negotiations Bioshield Procurement Contract Net Loss Per Share
Neumune Neumune Rfp Acute Radiation Syndrome
New Accounting Pronouncement New Accounting Pronouncements
New Plan Benefits Nformation Egarding Oard Irectors Ommittees
Nominating Committee Nominating Corporate Governance Committee
Non-employee Directors Equity Incentive Plan Not Obtain Government Regulatory Approval Drug Candidates Unable
Not Obtain Government Regulatory Approval Products Cannot Sell Not Successfully Commercialize Drug Candidates Never Achieve Profitability
Not Successfully Commercialize Products Never Achieve Profitability Notes Financial Statements
Notice Certain Events Notice Exercise
Notices Number Qualifications Term Office
Numbers Oard Irectors Ecommends
Ode Usiness Onduct Thics Off-balance Sheet Arrangements
Offer Notice Officers
Offices Olicies Rocedures Ith Espect Elated Arty Ransactions
Ominee Lection Hree Ear Erm Xpiring 2011 Nnual Ominees Lection Hree Ear Erm Xpiring 2009 Nnual
Ominees Lection Hree Ear Erm Xpiring 2010 Nnual Ominees Lection Hree Ear Erm Xpiring 2012 Nnual
Ominees Lection Hree Erm Xpiring 2008 Nnual Eeting Ompensation Hilosophy
Ompensation Irectors Ompensation Ommittee Nterlocks Nsider Articipation
Oncology Prostate Cancer Ong Erm Ncentives Wards
Onqualified Eferred Ompensation Operations Review
Organization Ote Avor Ach Amed Ominee
Ote Avor Roposal Otential Ayments Pon Ermination Hange Ontrol
Other Agreements Commitments Other Autoimmune Diseases
Other Benefits Other Events
Other Information Other Securities Corporation
Ouseholding Roxy Aterials Ovenants Ompany
Overview Parachute Payments
Part Part Other Information
Patent Notice Patents
Paul Bagley Paying Proxy Solicitation
Payments Via Express Mail Check Payable Performance Measurement Comparison
Performance-based Stock Awards Pharmadigm
Phosphonol Phosphothioate Technology
Please Vote Date Promptly Return Proxy Enclosed Envelope Policies Procedures Respect Related Party Transactions
Pproval Olicies Preferred Shares
President Ceo Press Release
Primary Components Executive Compensation Private Placement Warrants
Pro Forma Disclosures Net Income Pro Forma Disclosures Net Loss
Products Development Property Equipment
Proposals Prostate Cancer
Ption Rants Ast Iscal Ear Ption Rovisions
Ption Xercises Tock Ested Pulmonary Diseases
Pulmonary Diseases Other Autoimmune Purchaser Representations Warranties
Purpose Pursuant Nasdaq Marketplace Rule 4803
Pursuant Requirements Securities Exchange Act 1934 Registrant Duly Pursuant Requirements Securities Exchange Act 1934 Report Been
Quantitative Qualitative Disclosures Market Risk Quorum Voting
Radiation Syndrome Medical Countermeasures Nuclear Terrorism Rants Lan Ased Wards
Rants Lan Ased Wards Iscal 2007 Rants Lan Ased Wards Iscal 2008
Receiving Materials Recent Accounting Pronouncements
Recent Developments Recent Progress Drug Development Programs
Recent Publicity Concerning Safety Certain Drug Products Resulted Recitals
Reclamation Notice Reclassifications
Redemption Redemption Exchange Rights
Registrants Telephone Number Including Area Code Registrants Telephone Number Including Area Code 858 587-9333
Reminder Page Intentionally Left Blank Reorganization
Report Independent Registered Public Accounting Firm Representations Warranties
Representatives Warrants Research Development
Restricted Stock Result Intensely Competitive Industry Not Gain Enough Market
Results Operations Results Operations Liquidity Needs Materially Negatively Affected Market
Revenue Recognition Reverse Stock Splits
Rheumatoid Arthritis Richard Hollis
Risk Factors Roceeds Ales Ommon Tock
Role Inflammation Salvatore Zizza
Schedule 14a Information Securities Exchange Act 1934
Securities Owned Corporation Securities Registered Pursuant Act
Securities Subject Extreme Price Fluctuations Adversely Affect Investment Security Ownership Certain Beneficial Owners Management
Series Warrants Severance Change Control Benefits
Shares Stock Signature
Signatures Special Meetings
Ssuance Nder 2005 Mployee Irectors Quity Ncentive Lan Ssuance Nder 2005 Quity Ncentive Lan
Staffing Strategy State Other Jurisdiction Incorporation
Status Other Development Programs Still Development Stage
Stock Option Plan Stock Plan
Stock Purchase Agreement Stock Subject 2005 Directors Plan
Stock Subject 2005 Equity Plan Stock-based Compensation
Stockholder Proposals Due Next Annual Meeting Stockholder Record Shares Registered Name
Stockholders Meetings Study Funding Agreement
Submission Matters Vote Securities Holders Substantial Sales Stock Impact Market Price Common
Summary Compensation Table 2006 Summary Data Presented
Technology Agreements Tenure Duties Officers
Termination Terms Options
Terms Other Equity Awards Terms Preferred Shares
Terms Restricted Stock Unit Awards Terms Stock Appreciation Rights
Terms Stock Purchase Awards Restricted Ther Atters
Therapy Forces Thomas Merigan
Through Sale Common Stock Warrants Tock Ption Rants Xercises
Tockholder Ommunications Oard Irectors Trading Securities Subject Extreme Price Fluctuations Adversely Affect
Transfers Trigger Flip-in Flip-over Rights
Type Diabetes Type Diabetes Market
Ulcerative Colitis Ummary Ompensation
Ummary Ompensation Able Unregistered Sales Equity Securities Proceeds
Update Revise Information Contained Press Release Result New Utstanding Quity Wards Iscal End
Vote Vote Annual Meeting
Votes Votes Counted
Votes Needed Approve Each Proposal Warrants Issued 2007 Weighted Average Exercise Price 2006
Washington 20549 What Mean Receive Proxy Card
What Quorum Requirement What Return Proxy Card Not Make Specific Choices
What Voting Wire Instructions
Wire Transfer Instructions Xecutive Fficers Enior Anagement
Xecutive Ompensation Xhibit 313
Year-end 2005 Financial Results Yes
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki